Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8355516rdf:typepubmed:Citationlld:pubmed
pubmed-article:8355516lifeskim:mentionsumls-concept:C1551338lld:lifeskim
pubmed-article:8355516lifeskim:mentionsumls-concept:C0026986lld:lifeskim
pubmed-article:8355516lifeskim:mentionsumls-concept:C0230463lld:lifeskim
pubmed-article:8355516lifeskim:mentionsumls-concept:C1704257lld:lifeskim
pubmed-article:8355516lifeskim:mentionsumls-concept:C1704258lld:lifeskim
pubmed-article:8355516lifeskim:mentionsumls-concept:C1515648lld:lifeskim
pubmed-article:8355516pubmed:issue8lld:pubmed
pubmed-article:8355516pubmed:dateCreated1993-9-23lld:pubmed
pubmed-article:8355516pubmed:abstractTextWe report four patients with myelodysplastic syndrome (MDS) with isochromosome i(17q) as the sole chromosomal anomaly. One patient was classified as refractory anemia (RA) and three as refractory anemia with excess of blasts (RAEB). All four patients shared several features such as male sex, advanced age, severe anemia, as well as a bone marrow with myeloproliferative characteristics: hypercellularity, prominent baso- and eosinophilia, and marked increase of micromegakaryocytes. We suggest that patients with i(17q) as the sole chromosomal anomaly may identify a distinct MDS with characteristics between MDS and chronic myeloproliferative disorders (CMPD).lld:pubmed
pubmed-article:8355516pubmed:languageenglld:pubmed
pubmed-article:8355516pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8355516pubmed:citationSubsetIMlld:pubmed
pubmed-article:8355516pubmed:statusMEDLINElld:pubmed
pubmed-article:8355516pubmed:monthAuglld:pubmed
pubmed-article:8355516pubmed:issn0145-2126lld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:WoessnerSSlld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:FlorensaLLlld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:MillaFFlld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:IrriguibleDDlld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:RiberaJ MJMlld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:GranadaIIlld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:SoléFFlld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:TorrabadellaM...lld:pubmed
pubmed-article:8355516pubmed:authorpubmed-author:VallespiTTlld:pubmed
pubmed-article:8355516pubmed:issnTypePrintlld:pubmed
pubmed-article:8355516pubmed:volume17lld:pubmed
pubmed-article:8355516pubmed:ownerNLMlld:pubmed
pubmed-article:8355516pubmed:authorsCompleteYlld:pubmed
pubmed-article:8355516pubmed:pagination717-20lld:pubmed
pubmed-article:8355516pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:meshHeadingpubmed-meshheading:8355516-...lld:pubmed
pubmed-article:8355516pubmed:year1993lld:pubmed
pubmed-article:8355516pubmed:articleTitleIsochromosome 17q as a sole anomaly: a distinct myelodysplastic syndrome entity?lld:pubmed
pubmed-article:8355516pubmed:affiliationUnitat d'Hematologia i Oncologia, Hospital Central L'Aliança, Barcelona, Spain.lld:pubmed
pubmed-article:8355516pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8355516pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed